BSX News and Press, Boston Scientific Corporation From 04/24/24

Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...

2024-04-24 06:32:48 ET More on Boston Scientific Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Boston...

Boston Scientific Announces Results for First Quarter 2024 PR Newswire MARLBOROUGH, Mass. , April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent o...

2024-04-23 14:06:28 ET More on Boston Scientific Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Boston...

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...

2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...

2024-04-18 12:10:02 ET More on Cisco, Goldman Sachs, etc. Cisco Won't Stay This Cheap For Long Goldman Sachs: A Profit Machine In A Turbulent Market? Goldman Sachs Q1 Earnings: A Solid Start To 2024, But Second Half Faces New Uncertainties Arista, Cisco remai...

2024-04-17 16:15:11 ET More on Boston Scientific Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Needha...

2024-04-15 09:00:04 ET Marie Thibault from BTIG issued a price target of $74.00 for BSX on 2024-04-15 07:35:00. The adjusted price target was set to $74.00. At the time of the announcement, BSX was trading at $68.07. The overall price target consensus is at $56.89 with h...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...